News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
95,948 Results
Type
Article (5512)
Company Profile (50)
Press Release (90386)
Section
Business (25988)
Career Advice (281)
Deals (3936)
Drug Delivery (10)
Drug Development (18319)
Employer Resources (17)
FDA (2462)
Job Trends (1960)
News (49913)
Policy (3799)
Tag
Academia (358)
Alliances (7742)
Alzheimer's disease (267)
Approvals (2468)
Bankruptcy (22)
Best Places to Work (1669)
Biotechnology (37)
Breast cancer (47)
Cancer (318)
Cardiovascular disease (26)
Career advice (240)
CAR-T (21)
Cell therapy (63)
Clinical research (14981)
Collaboration (113)
Compensation (35)
COVID-19 (385)
C-suite (20)
Data (448)
Diabetes (26)
Diagnostics (939)
Earnings (8879)
Events (14333)
Executive appointments (66)
FDA (2634)
Funding (85)
Gene therapy (46)
GLP-1 (87)
Government (479)
Healthcare (2044)
Infectious disease (400)
Inflammatory bowel disease (40)
Interviews (50)
IPO (1898)
Job creations (376)
Job search strategy (209)
Layoffs (47)
Legal (415)
Lung cancer (49)
Lymphoma (26)
Manufacturing (35)
Medical device (944)
Medtech (944)
Mergers & acquisitions (2097)
Metabolic disorders (67)
Neuroscience (371)
NextGen Class of 2024 (783)
Non-profit (419)
Northern California (439)
Obesity (30)
Opinion (34)
Parkinson's disease (27)
Patents (22)
People (7791)
Phase I (4632)
Phase II (6770)
Phase III (5057)
Pipeline (114)
Postmarket research (420)
Preclinical (1979)
Radiopharmaceuticals (44)
Rare diseases (75)
Real estate (652)
Regulatory (3223)
Research institute (422)
Resumes & cover letters (35)
Schizophrenia (20)
Southern California (378)
Startups (697)
United States (3019)
Vaccines (59)
Date
Today (3)
Last 7 days (24)
Last 30 days (362)
Last 365 days (7052)
2025 (12)
2024 (7164)
2023 (7797)
2022 (9582)
2021 (9911)
2020 (8462)
2019 (6425)
2018 (4608)
2017 (5150)
2016 (4562)
2015 (5268)
2014 (3601)
2013 (2857)
2012 (3000)
2011 (3055)
2010 (2809)
Location
Africa (97)
Asia (5434)
Australia (834)
California (946)
Canada (265)
China (63)
Colorado (37)
Connecticut (40)
Delaware (21)
Europe (13960)
Florida (69)
Illinois (45)
Indiana (39)
Japan (22)
Kansas (53)
Maryland (121)
Massachusetts (594)
Michigan (39)
Minnesota (27)
New Jersey (183)
New York (172)
North Carolina (198)
Northern California (439)
Ohio (37)
Pennsylvania (144)
South America (99)
Southern California (378)
Texas (120)
Washington State (90)
95,948 Results for "character biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Character Biosciences Strengthens Leadership Team with Appointment of Laura Carter, Ph.D. as Chief Scientific Officer
Character Biosciences, a drug discovery and development company leveraging human genetics and medical imaging-based machine learning to target disease progression, announced the appointment of Laura Carter, Ph.D. as Chief Scientific Officer.
September 13, 2023
·
2 min read
Biotech Beach
Neurocrine Biosciences Presents CAHtalyst™ Adult Study Baseline Characteristics and Data on Impact of Supraphysiologic Glucocorticoid Therapy at AACE 2024
Neurocrine Biosciences today announced that it will present CAHtalyst™ Adult Phase 3 clinical study baseline characteristics for adults with congenital adrenal hyperplasia.
May 9, 2024
·
10 min read
Biotech Beach
Neurocrine Biosciences to Present Phase 3 Baseline Characteristics Data from the CAHtalyst™ Program of Crinecerfont in CAH
Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that it will present key information from its neuroendocrinology pipeline, including baseline characteristics data from its CAHtalyst™ Program.
May 7, 2024
·
9 min read
Press Releases
Rigaku BioScience Lab Opens in USA
November 21, 2024
·
3 min read
Biotech Beach
Neurocrine Biosciences Presented CAHtalyst™ Pediatric Study Baseline Characteristics and CAHtalog™ Registry Data at PES 2024
Neurocrine Biosciences, Inc. (Nasdaq: NBIX), today presented the CAHtalyst™ Pediatric Phase 3 clinical study baseline characteristics data for children and adolescents with congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency enrolled in the study, along with CAHtalog™ Registry data assessing glucocorticoid treatment patterns in pediatric and adult patients with CAH.
May 3, 2024
·
10 min read
Press Releases
Solid Biosciences Added to the Nasdaq Biotechnology Index
December 24, 2024
·
1 min read
Press Releases
Kuros Biosciences Expands into Extremities Markets
November 19, 2024
·
5 min read
Press Releases
OraSure Technologies Acquires Sherlock Biosciences
December 20, 2024
·
9 min read
Press Releases
Ensysce Biosciences Regains Full Compliance with Nasdaq
December 23, 2024
·
3 min read
Press Releases
Arcus Biosciences Announces New Employment Inducement Grants
December 3, 2024
·
1 min read
1 of 9,595
Next
